Epidemiological pathology of Aβ deposition in the ageing brain in CFAS: addition of multiple Aβ-derived measures does not improve dementia assessment using logistic regression and machine learning approaches.
Journal
Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673
Informations de publication
Date de publication:
05 12 2019
05 12 2019
Historique:
received:
22
11
2019
accepted:
25
11
2019
entrez:
7
12
2019
pubmed:
7
12
2019
medline:
26
9
2020
Statut:
epublish
Résumé
Aβ-amyloid deposition is a key feature of Alzheimer's disease, but Consortium to Establish a Registry for Alzheimer's Disease (CERAD) assessment, based on neuritic plaque density, shows a limited relationships to dementia. Thal phase is based on a neuroanatomical hierarchy of Aβ-deposition, and in combination with Braak neurofibrillary tangle staging also allows derivation of primary age-related tauopathy (PART). We sought to determine whether Thal Aβ phase predicts dementia better than CERAD in a population-representative cohort (n = 186) derived from the Cognitive Function and Ageing Study (CFAS). Cerebral amyloid angiopathy (CAA) was quantitied as the number of neuroanatomical areas involved and cases meeting criteria for PART were defined to determine if they are a distinct pathological group within the ageing population. Agreement with the Thal scheme was excellent. In univariate analysis Thal phase performed less well as a predictor of dementia than CERAD, Braak or CAA. Logistic regression, decision tree and linear discriminant analysis were performed for multivariable analysis, with similar results. Thal phase did not provide a better explanation of dementia than CERAD, and there was no additional benefit to including more than one assessment of Aβ in the model. Number of areas involved by CAA was highly correlated with assessment based on a severity score (p < 0.001). The presence of capillary involvement (CAA type I) was associated with higher Thal phase and Braak stage (p < 0.001). CAA was not associated with microinfarcts (p = 0.1). Cases satisfying pathological criteria for PART were present at a frequency of 10.2% but were not older and did not have a higher likelihood of dementia than a comparison group of individuals with similar Braak stage but with more Aβ. They also did not have higher hippocampal-tau stage, although PART was weakly associated with increased presence of thorn-shaped astrocytes (p = 0.048), suggesting common age-related mechanisms. Thal phase is highly applicable in a population-representative setting and allows definition of pathological subgroups, such as PART. Thal phase, plaque density, and extent and type of CAA measure different aspects of Aβ pathology, but addition of more than one Aβ measure does not improve dementia prediction, probably because these variables are highly correlated. Machine learning predictions reveal the importance of combining neuropathological measurements for the assessment of dementia.
Identifiants
pubmed: 31806014
doi: 10.1186/s40478-019-0858-4
pii: 10.1186/s40478-019-0858-4
pmc: PMC6896261
doi:
Substances chimiques
Amyloid beta-Peptides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
198Subventions
Organisme : Medical Research Council
ID : MR/J004308/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0900582
Pays : United Kingdom
Organisme : Alzheimer's Society
ID : AS-PG-14-015
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1100540
Pays : United Kingdom
Organisme : Alzheimer's Society
ID : AS-PG-17-007
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9901400
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0300126
Pays : United Kingdom
Organisme : Medical Research Council
ID : G090052
Pays : United Kingdom
Références
J Neuropathol Exp Neurol. 2017 Jul 1;76(7):605-619
pubmed: 28591867
Acta Neuropathol. 2016 Jan;131(1):87-102
pubmed: 26659578
Acta Neuropathol. 2009 Mar;117(3):309-20
pubmed: 19184666
Neurology. 1991 Apr;41(4):479-86
pubmed: 2011243
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Stroke. 2016 Aug;47(8):2010-6
pubmed: 27338926
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
EMBO Mol Med. 2016 Jun 01;8(6):595-608
pubmed: 27025652
Brain Pathol. 2016 May;26(3):371-86
pubmed: 26193084
Alzheimers Dement (Amst). 2018 Nov 12;11:1-9
pubmed: 30569013
Ann Neurol. 2011 Feb;69(2):320-7
pubmed: 21387377
Brain Inform. 2016 Mar;3(1):17-27
pubmed: 27747596
Neurology. 2002 Jun 11;58(11):1629-34
pubmed: 12058090
J Neuropathol Exp Neurol. 2016 Jun;75(6):516-26
pubmed: 27105663
Neurology. 2015 Dec 1;85(22):1930-6
pubmed: 26537052
Brain. 2010 May;133(Pt 5):1328-41
pubmed: 20403962
Am J Neurodegener Dis. 2014 Mar 28;3(1):19-32
pubmed: 24754000
Neuropathol Appl Neurobiol. 2017 Aug;43(5):409-418
pubmed: 27664944
Acta Neuropathol. 2015 May;129(5):749-56
pubmed: 25628035
PLoS Med. 2009 Nov;6(11):e1000180
pubmed: 19901977
Ann Neurol. 2011 Jan;69(1):181-92
pubmed: 21280088
Acta Neuropathol Commun. 2018 Jul 23;6(1):64
pubmed: 30037350
Acta Neuropathol Commun. 2016 Feb 08;4:11
pubmed: 26857919
Psychol Med. 1998 Mar;28(2):319-35
pubmed: 9572090
Acta Neuropathol. 2006 Oct;112(4):389-404
pubmed: 16906426
Int J Geriatr Psychiatry. 2006 Jul;21(7):681-7
pubmed: 16802283
Arch Neurol. 1997 Aug;54(8):1001-9
pubmed: 9267975
Int J Epidemiol. 2006 Oct;35(5):1140-5
pubmed: 16980700
Acta Neuropathol. 2014 Oct;128(4):543-50
pubmed: 24916271
Neuropathol Appl Neurobiol. 2017 Oct;43(6):505-513
pubmed: 27783888
Neuropathol Appl Neurobiol. 2013 Aug;39(5):498-509
pubmed: 23163235
Neurobiol Aging. 2004 Mar;25(3):397-405
pubmed: 15123344
Acta Neuropathol. 2014 Dec;128(6):755-66
pubmed: 25348064
Int Psychogeriatr. 2011 Mar;23(2):274-9
pubmed: 20637140
Biochem Soc Trans. 2012 Aug;40(4):711-5
pubmed: 22817721
J Alzheimers Dis. 2011;25(2):359-72
pubmed: 21422529
Acta Neuropathol. 2016 Dec;132(6):875-895
pubmed: 27770234
Acta Neuropathol. 2012 Nov;124(5):693-704
pubmed: 22802095
N Engl J Med. 2009 May 28;360(22):2302-9
pubmed: 19474427
Brain. 2009 May;132(Pt 5):1324-34
pubmed: 19321462
Acta Neuropathol. 2012 Jan;123(1):1-11
pubmed: 22101365
Brain. 2015 May;138(Pt 5):1370-81
pubmed: 25805643
Acta Neuropathol. 2018 May;135(5):681-694
pubmed: 29574591
Neurology. 2002 Jun 25;58(12):1791-800
pubmed: 12084879
Lancet. 2001 Jan 20;357(9251):169-75
pubmed: 11213093
Dement Geriatr Cogn Disord. 2012;34(1):15-24
pubmed: 22868294